Seasonal influenza vaccination of high-risk adults (Q30387979)

21 June 2017

1 reference

title

Seasonal influenza vaccination of high-risk adults (English)

1 reference

21 June 2017

4

Odile Launay

1 reference

21 June 2017

Paul Loubet

1

1 reference

21 June 2017

Pierre Loulergue

series ordinal

2

1 reference

21 June 2017

Florence Galtier

series ordinal

3

1 reference

21 June 2017

publication date

12 May 2016

1 reference

Expert Review of Vaccines

21 June 2017

published in

1 reference

21 June 2017

volume

15

1 reference

21 June 2017

issue

12

1 reference

21 June 2017

page(s)

1507-1518

1 reference

Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Vaccination rates among the general adult population and high-risk groups in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Improving immunogenicity and effectiveness of influenza vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impact of influenza vaccination on seasonal mortality in the US elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Efficacy of high-dose versus standard-dose influenza vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effectiveness of influenza vaccine in the community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination and mortality: differentiating vaccine effects from bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Assessing the safety of influenza vaccination in specific populations: children and the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccine for patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The safety of inactivated influenza vaccine in adults and children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Risk of myocardial infarction and stroke after acute infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccines for preventing cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Epidemiology of acute infections among patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Mortality of dialysis patients according to influenza and pneumococcal vaccination status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Hepatic decompensation in patients with cirrhosis during infection with influenza A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Clinical impact of influenza immunization in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination in patients with cirrhosis and in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Diabetes and the severity of pandemic influenza A (H1N1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The impact of diabetes on the pathogenesis of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Long-Term Immunogenicity and Safety of a Conventional Influenza Vaccine in Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The antibody response to influenza vaccination is not impaired in type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Association between obesity and vulnerability and serologic response to influenza vaccination in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Obesity is associated with impaired immune response to influenza vaccination in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

H1N1 2009 influenza virus infection during pregnancy in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The influence of pregnancy on systemic immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Risk of fetal death after pandemic influenza virus infection or vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effects of influenza on pregnant women and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Pregnancy modifies the antibody response to trivalent influenza immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination of pregnant women and protection of their infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effectiveness of maternal influenza immunization in mothers and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impact of maternal immunization on influenza hospitalizations in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Should expectant mothers be vaccinated against flu? A safety review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Safety of influenza vaccines in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Trivalent inactivated influenza vaccine and spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Maternal influenza vaccine and risks for preterm or small for gestational age birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Effect of influenza vaccination in the first trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Maternal Influenza Vaccination and Risk for Congenital Malformations: A Systematic Review and Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Cardiopulmonary Hospitalizations During Influenza Season in Adults and Adolescents With Advanced HIV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Vaccination of patients with autoimmune inflammatory rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Epidemiology and outcomes of serious influenza-related infections in the cancer population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Response to influenza virus vaccination during chemotherapy in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza immunization of adult patients with malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Serological immune responses to influenza vaccine in patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza virus infection in adult solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza virus vaccination and kidney graft rejection: causality or coincidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Vaccination of the solid organ transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Immunization in end-stage renal disease: opportunity to improve outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Dutch influenza vaccination rate drops for fifth consecutive year

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Vaccination coverage against hepatitis A and B viruses, Streptococcus pneumoniae, seasonal flu, and A(H1N1)2009 pandemic influenza in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Toward a universal influenza virus vaccine: prospects and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

Influenza Immunization in Pregnancy — Antibody Responses in Mothers and Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1188696

10.1080/14760584.2016.1188696

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference